Frequency of current measures performed

ESR in last 3 months (%)

74

72

0.73

CRP in last 3 months (%)

79

70

0.36

TJC in last 3 months (%)

91

96

0.68

SJC in last 3 months (%)

96

95

0.50

Patient Global VAS (%)

75

64

0.82

MD Global VAS (%)

66

68

0.49

HAQ done (%)

75

56

0.22

Composite Score Calculated (%)

25

25

0.88

CDAI (0 - 39)

20

26

0.17

Current measurement results (mean and range)

CRP (0.2 - 57)

8.0 (0.3 - 57)

5.9 (0.2 - 42)

0.17

ESR (0 - 65)

14.4 (0 - 65)

8.9 (2 - 41)

0.05

TJC (0 - 32)

2.9 (0 - 25)

2.2 (0 - 32)

0.92

SJC (0 - 25)

2.9 (0 - 25)

2.2 (0 - 24)

0.47

Patient Global (0 - 10)

3.3

3.0

0.61

HAQ (0 - 3)

0.68

0.75

0.66

MD Global (0 - 10)

2.7

2.3

0.57

CDAI (0 - 39)

8.7 (0 - 33)

5.6 (0 - 21)

0.59

Current treatment

Methotrexate (%)

47

53

0.52

Sulfasalazine (%)

9

11

0.62

Leflunomide (%)

10

16

0.36

Steroids (%)

9

4

0.32

Biologics (%)

37

26

0.17

Previous drugs not currently taking

Methotrexate (%)

48

37

0.23

Sulfasalazine (%)

46

23

0.01

Leflunomide (%)

25

16

0.22

Steroids (%)

12

4

0.13

Biologics (%)

21

17

0.55

% with steroids given at current visit (intraarticular or systemic)

17

10

0.24

% with DMARD change at current visit

31

25

0.37

Reasons for no change despite active disease

Patient refused (N)

9

3

Not in steady state yet (N)

5

0

Contraindicated or Comorbidity (N)

3

3

Other (N)

3

9